Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-01-11 @ 6:08 PM
Study NCT ID:
NCT02740920
Status:
TERMINATED
Last Update Posted:
2023-08-25
First Post:
2016-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker
Sponsor:
Canadian Cancer Trials Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-06
First Submit QC Date:
None
Study First Post Date:
2016-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-26
Results First Submit QC Date:
None
Results First Post Date:
2019-09-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-03
Last Update Post Date:
2023-08-25
Last Update Post Date Type:
ACTUAL